ResultsIQ

ResultsIQ › Latest results › Gem Aromatics Limited

Gem Aromatics Limited Q1 FY27 earnings call summary

NSE: GEMAROMA · BSE: 544491

Earnings call of 14 Aug 2026, summarised by AI from the filing.

Gem Aromatics Q1 FY27 standalone revenue ₹83 cr, consolidated loss ₹7.9 cr; Krystal products to exceed 50% of revenue in FY28.

Key takeaways

  1. Guidance Krystal products to be more than 50% of overall revenue in FY28; FY27 not guided.
  2. Change Consolidated loss due to higher depreciation ₹9.1 cr and timing mismatch of costs and revenue.
  3. Driver Commercialization of new verticals: Safranal, cooling agents, phenol derivatives.
  4. Risk Floods in Madagascar disrupted clove raw material availability and pricing.

Original filing on BSE

Gem Aromatics Limited Q1 FY27 results

As filed: Revenue ₹98.9 cr (+12% year on year), EBITDA ₹3.3 cr (−79% year on year), PAT −₹7.9 cr (−198% year on year), EBITDA margin 3.4% (−1,000 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹112 cr, EBITDA ₹15.1 cr, PAT ₹11.9 cr, EBITDA margin 13.4%. Not scored. No result for the same quarter last year. Share price after the results: +10.9% in 29 days (Nifty 500: +2.4%).
  • Q3 FY26: Revenue ₹83.9 cr, EBITDA ₹7.6 cr, PAT ₹4.2 cr, EBITDA margin 9.1%. Not scored. No result for the same quarter last year. Share price after the results: +28.9% in 30 days (Nifty 500: +2.8%).
  • Q2 FY26: Revenue ₹98.0 cr, EBITDA ₹5.0 cr, PAT ₹4.0 cr, EBITDA margin 5.1%. Not scored. No result for the same quarter last year. Share price after the results: −28.9% in 29 days (Nifty 500: −0.4%).
  • Q1 FY26: Revenue ₹76.0 cr, EBITDA ₹10.0 cr, PAT ₹7.0 cr, EBITDA margin 13.2%. Not scored. No result for the same quarter last year. Share price after the results: −13.1% in 28 days (Nifty 500: +0.6%).

Past price moves after results do not indicate future moves. Not a recommendation.

Gem Aromatics Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.